Periodontal Therapeutics Market By Treatment Type (Systemic Antibiotics, Local Antibodies) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Periodontal therapeutics are non-surgical methods of treating periodontal diseases. Periodontal diseases are infections of the structures around the teeth, including the gums, the cementum that covers the root, the periodontal ligament, and the alveolar bone.

The report titled "Global Periodontal Therapeutics Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" offers strategic insights into the overall periodontal therapeutics market, along with the market's size and estimates for the duration of 2017 to 2025. The research study covers an in-depth analysis of market segments based on the therapeutic type and different geographical regions.

The report also includes sections on the competitive profiling of the leading players in the global periodontal therapeutics market, attractive investment propositions, and market positioning of key manufacturers to assist strategic decision-makers.

Geographically, the global periodontal therapeutics market is studied for the following regional markets:

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Rest of Europe
• Asia-Pacific
• China
• Japan
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• rest of Latin America
• Middle East and Africa
• GCC
• the remainder of MEA

The market size and forecast for these regional and country-level markets are presented in this study for the period 2015–2025. Market growth rates for the forecast period 2017–2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global periodontal therapeutics market.

Tools such as key player market positioning and appealing investment propositions provide readers with insights into the global periodontal therapeutics market's competitive scenario. This report concludes with a company profiles section that highlights major information about the key players engaged in the global periodontal therapeutics market. In-depth competitive environment analysis and historical year (2015) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global periodontal therapeutics market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Based on the type of treatment, the periodontal therapeutics market is segmented into:

Systemic AntibioticsDoxycycline

• Minocycline
• Metronidazole
• Others

Local Antibodies

• Arestin
• Chlorhexidine
• Others

Periodontal diseases are infections of the structures around the teeth, including the gums, the cementum that covers the root, the periodontal ligament, and the alveolar bone. In the initial stage of periodontal disease, gingivitis, the infection affects only the gums. In more severe forms of the disease, all of the supporting tissues are involved. Periodontal disease, if left untreated, results in chronic inflammation, leading to insulin resistance, reduced glucose tolerance, and the risk of diabetes. People with diabetes are at a higher risk of getting periodontitis than people without diabetes.

According to the World Health Organization (WHO), globally, an estimated 422 million adults were living with diabetes in 2014, and that number is expected to double by 2025. A large number of diabetic people in the world will be in emerging economies such as India and China. Hence, the increasing prevalence of diabetes is driving the global periodontal therapeutics market. On the basis of treatment, the global periodontal therapeutics market has been segmented in terms of systemic and local antibiotics. Systemic antibiotics held the largest share due to product affordability, availability, and high market penetration, which would further drive the periodontal therapeutics market during the forecast period.

For the purpose of this study, the global periodontal therapeutics market is categorized as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

For the purpose of this study, the global periodontal therapeutics market is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In the base year 2016, North America dominated the global periodontal therapeutics market due to the higher awareness regarding periodontal diseases as compared to other regions.

Moreover, the prevalence of periodontal diseases due to sedentary lifestyles, an efficient reimbursement scenario, and a rising geriatric population are the major driving factors for the rise in the periodontal therapeutics market in North America. Asia Pacific has emerged as the most lucrative market for periodontal therapeutics due to its large patient pool, growing healthcare infrastructure, and high expenditure.

Frequently Asked Question: